Alamar Biosciences

Alamar Biosciences Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Alamar Biosciences, Biotechnology company, 47071 Bayside Parkway, Fremont, CA.

Alamar Biosciences is a privately held life sciences company with a mission to transform the field of proteomics to enable the early detection of cancer and other diseases.

Collecting high-quality protein biomarker data from dried blood spots starts with a reliable extraction workflow. The NU...
06/05/2026

Collecting high-quality protein biomarker data from dried blood spots starts with a reliable extraction workflow.

The NULISA™ DBS Extraction Kit provides a standardized approach for recovering protein analytes from dried blood and dried plasma spots collected on major microsampling platforms, including Capitainer, Mitra, Tasso, and Telimmune devices.

Designed to work seamlessly with NULISAseq™ panels, the DBS workflow enables researchers to:
• Support remote, decentralized, and longitudinal study designs
• Generate high-sensitivity proteomic data from microsamples
• Use a device-agnostic workflow across leading collection platforms
• Scale sample processing with a high-throughput extraction workflow

Explore the workflow graphic below to see how DBS samples move from collection to extraction to ultra-sensitive proteomic analysis.

👉 Learn more about the NULISA DBS Extraction Kit and how it fits into your workflow: https://na2.hubs.ly/H05Y_f80

06/03/2026

Join Alamar Biosciences at the 2026 FOCIS Annual Meeting and discover how ultra-sensitive NULISA™ proteomics is helping researchers unlock deeper insights into immune biology.

Visit us at booth 15 to learn about our NULISAseq™ panels and NULISA assays for immunology research, designed to support biomarker discovery, immune profiling, and translational research with high sensitivity.

Stop by to connect with our team and explore how precision proteomics is advancing immunology research.

📍 SF Marriott Marquis, San Francisco, CA
📍 Booth 15
📅 June 23–26, 2026

We look forward to seeing you there!

Learn more: https://na2.hubs.ly/H05WV3n0

06/02/2026

🩸 Introducing the NULISA™ Dried Blood Spot (DBS) Extraction Kit

Unlock high-quality, multiplex proteomic data from dried blood and plasma spot microsamples with a standardized, high-throughput workflow. Just a few drops of blood become a stable, ambient-shippable specimen, enabling remote collection and longitudinal studies.

Paired with NULISA’s ultra high-sensitivity detection, the DBS Extraction Kit delivers 85–95% target detectability across NULISA CNS and Inflammation panels on most devices tested, and is validated across leading microsampling platforms including Capitainer, Telimmune, Mitra, and Tasso.

Why it matters:
✅ Standardized workflow
✅ Device-agnostic compatibility
✅ High-throughput processing
✅ Enables remote and longitudinal research

Together, these capabilities expand how and where proteomics can be applied, supporting broader use across translational and population health research.

Learn how the NULISA™ DBS Extraction Kit enables high-quality proteomic data from remote microsamples: https://na2.hubs.ly/H05TcjW0

Read the full press release: https://na2.hubs.ly/H05T9xN0

06/01/2026

Multiple sclerosis is a complex and highly variable disease, making early detection, patient stratification, and disease monitoring critical to advancing research and improving outcomes.

At Alamar Biosciences, we are committed to empowering researchers with ultra-sensitive proteomics tools that enable the measurement of low-abundance biomarkers from accessible biofluids. By uncovering biological signals linked to neuroinflammation, neurodegeneration, and disease progression, researchers can gain deeper insights into the mechanisms driving MS and other neurological disorders.

As the scientific community continues to push the boundaries of biomarker discovery, we are proud to support the work that is shaping a future of earlier detection, more precise monitoring, and ultimately, better care for people living with multiple sclerosis.

05/22/2026

🚨 We’re heading to the 7th World Parkinson Congress in Phoenix, Arizona!

Join Alamar Biosciences as the global Parkinson’s disease community comes together to explore the latest breakthroughs in PD research, biomarker discovery, and emerging therapeutics.

Visit us at booth 328 to discover how the NULISAseq™ Neuro 220 Panel is enabling ultra-sensitive, high-multiplex proteomics with analysis of 220 biomarkers from biofluids, including 25 new biomarkers associated with Parkinson’s disease.

Learn more about our presence at WPC 2026: https://na2.hubs.ly/H05H-Wl0

🚨 Don’t Miss the 2026 Summit Advancing TDP-43 Biomarkers happening this Thursday! Register now before virtual registrati...
05/19/2026

🚨 Don’t Miss the 2026 Summit Advancing TDP-43 Biomarkers happening this Thursday! Register now before virtual registration closes.

Hosted by the University of Wisconsin–Madison and the Wisconsin ADRC, this summit will bring together leaders in neurodegeneration research to discuss the latest advances and emerging opportunities in TDP-43 biomarker discovery.

Hear from co-hosts and leaders in the field, Dr. Henrik Zetterberg (University of Gothenburg), Dr. Hartmuth Kolb (Enigma Biomedical USA), and Dr. Sterling Johnson (University of Wisconsin), during collaborative discussions focused on accelerating progress in neurodegenerative disease research.

Be a part of the conversation shaping the next phase of TDP-43 and ADRD research by joining virtually for live presentations from experts across the research community.

Secure your virtual spot today: https://na2.hubs.ly/H05BhT50

🧠 Ultra-sensitive proteomics for neurodegeneration live from Amsterdam UMCOn May 21, Amsterdam UMC will host a scientifi...
05/07/2026

🧠 Ultra-sensitive proteomics for neurodegeneration live from Amsterdam UMC

On May 21, Amsterdam UMC will host a scientific meeting marking the introduction of the NULISA™ platform at Amsterdam UMC, bringing together international researchers to discuss advances in ultra-sensitive proteomics and biomarker research in dementia and multiple sclerosis.

The program will feature a technical overview of NULISA™ technology alongside scientific perspectives on emerging applications and biological insights across neurology, immunology, and translational research.

Featured speakers include:
🔹 Prof. Charlotte Teunissen (Amsterdam UMC)
🔹 Prof. Monique Breteler (DZNE)
🔹 Prof. Jonathan Rohrer (UCL)
🔹 Prof. Amy Fu (Hong Kong University of Science and Technology)
🔹 Dr. Gemma Salvadó (Barcelonaβeta & Lund University)

Unable to attend in person? A live online option will be available.

👉 View the program and register: https://na2.hubs.ly/H05kGw60

📍 We'll be at ###IV AINI Congress in Rome! This annual meeting of the Italian Society of Neuroimmunology (AINI) brings...
04/30/2026

📍 We'll be at ###IV AINI Congress in Rome!

This annual meeting of the Italian Society of Neuroimmunology (AINI) brings together leading researchers, clinicians, and early-career scientists advancing the understanding of neuroinflammatory and immune-mediated neurological disease.

🎤 Featured Speaking Session
Multiple sclerosis fluid biomarker signature across a cohort with deeply phenotyped cognitive function

Presented by {{linkedin_mention(urn:li:person:AsTNMWs7Qy|Anna Wojdała)}}, PhD ({{linkedin_mention(urn:li:organization:4083|Amsterdam UMC)}}), a recipient of our NULISAseq™ CNS Disease Panel 120 Grant Program, this session will explore how ultra-sensitive, multiplex proteomics can uncover fluid biomarker signatures linked to cognitive function in multiple sclerosis, helping to refine disease phenotyping and deepen understanding of underlying biology.

Be sure to add this session to your schedule.

👉 Learn more: https://na2.hubs.ly/H05cfh70

04/29/2026

🧬 International Day of Immunology

The signals that shape immune response are often the hardest to see.

Alamar’s ultra-sensitive NULISA technologies are designed to detect what others miss, empowering researchers to measure low-abundance biomarkers and uncover the biology driving disease.

We're proud to support the research advancing the boundaries of immunology.

04/27/2026

📍 Canadian Society for Immunology 2026

Happening this week in Winnipeg, leading researchers and clinicians will come together to advance the frontiers of immunology. We’re excited to connect with the Canadian immunology community and contribute to conversations shaping the future of immune profiling.

We’ll be sharing how the NULISA™ platform supports ultra-sensitive, multiplex protein analysis enabling detection of low-abundance biomarkers and deeper insights into complex biological systems.

Visit us at our table to learn how NULISA can support your research.

Address

47071 Bayside Parkway
Fremont, CA
94538

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Alamar Biosciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category